Dong Shuming, Dong Yushan, Liu Bin, Liu Jing, Liu Shikai, Zhao Zhiyu, Li Wenting, Tian Boshi, Zhao Ruoxi, He Fei, Gai Shili, Xie Ying, Yang Piaoping, Zhao Yanli
Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Material Sciences and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.
Department of Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, P. R. China.
Adv Mater. 2022 Feb;34(7):e2107054. doi: 10.1002/adma.202107054. Epub 2022 Jan 9.
Clinical applications of nanozyme-initiated chemodynamic therapy (NCDT) have been severely limited by the poor catalytic efficiency of nanozymes, insufficient endogenous hydrogen peroxide (H O ) content, and its off-target consumption. Herein, the authors developed a hollow mesoporous Mn/Zr-co-doped CeO tandem nanozyme (PHMZCO-AT) with regulated multi-enzymatic activities, that is, the enhancement of superoxide dismutase (SOD)-like and peroxidase (POD)-like activities and inhibition of catalase (CAT)-like activity. PHMZCO-AT as a H O homeostasis disruptor promotes H O evolution and restrains off-target elimination of H O to achieve intensive NCDT. PHMZCO-AT with SOD-like activity catalyzes endogenous superoxide anion (O ) into H O in the tumor region. The suppression of CAT activity and depletion of glutathione by PHMZCO-AT largely weaken the off-target decomposition of H O to H O. Elevated H O is then catalyzed by the downstream POD-like activity of PHMZCO-AT to generate toxic hydroxyl radicals, further inducing tumor apoptosis and death. T -weighted magnetic resonance imaging and X-ray computed tomography imaging are also achieved using PHMZCO-AT due to the existence of paramagnetic Mn and the high X-ray attenuation ability of elemental Zr, permitting in vivo tracking of the therapeutic process. This work presents a typical paradigm to achieve intensive NCDT efficacy by regulating multi-enzymatic activities of nanozymes to perturb the H O homeostasis.
纳米酶启动的化学动力疗法(NCDT)的临床应用一直受到纳米酶催化效率低、内源性过氧化氢(H₂O₂)含量不足及其脱靶消耗的严重限制。在此,作者开发了一种具有调控多酶活性的中空介孔Mn/Zr共掺杂CeO串联纳米酶(PHMZCO-AT),即增强超氧化物歧化酶(SOD)样和过氧化物酶(POD)样活性并抑制过氧化氢酶(CAT)样活性。PHMZCO-AT作为一种H₂O₂稳态破坏剂,促进H₂O₂生成并抑制H₂O₂的脱靶消除,以实现强化的NCDT。具有SOD样活性的PHMZCO-AT在肿瘤区域将内源性超氧阴离子(O₂⁻)催化为H₂O₂。PHMZCO-AT对CAT活性的抑制和谷胱甘肽的消耗大大削弱了H₂O₂向H₂O的脱靶分解。然后,升高的H₂O₂被PHMZCO-AT下游的POD样活性催化生成有毒的羟基自由基,进一步诱导肿瘤凋亡和死亡。由于顺磁性Mn的存在以及元素Zr的高X射线衰减能力,使用PHMZCO-AT还可实现T加权磁共振成像和X射线计算机断层扫描成像,从而允许在体内跟踪治疗过程。这项工作提出了一个典型的范例,即通过调节纳米酶的多酶活性来扰乱H₂O₂稳态,以实现强化的NCDT疗效。